Targeting the anti-inflammatory effects of high-density lipoprotein

Area of Science:

• Cardiovascular Science
• Immunology
• Lipid Metabolism

Background:

• Systemic inflammation can impair the anti-inflammatory properties of high-density lipoprotein (HDL) particles.
• In inflammatory conditions like atherosclerosis, modified HDLs can paradoxically promote inflammation by increasing macrophage recruitment and activation.

Purpose of the Study:

• To review how systemic inflammation affects HDL function.
• To discuss the pro-inflammatory modifications of HDL in atherosclerosis.
• To explore potential therapeutic strategies targeting HDL function.

Main Methods:

• Literature review of studies investigating HDL function in inflammatory states.
• Analysis of mechanisms by which HDL becomes pro-inflammatory.
• Evaluation of current and potential therapeutic interventions.

Main Results:

• Inflammation-induced HDL modifications can enhance macrophage recruitment and activation.
• Modified HDLs upregulate endothelial cell adhesion molecules, promoting vascular inflammation.
• HDLs can participate in the oxidation of low-density lipoproteins (LDLs), exacerbating atherosclerosis.

Conclusions:

• Statins, apolipoprotein A-I mimetic peptides, and lifestyle changes may counteract pro-inflammatory HDL features.
• Targeting specific functional aspects of HDLs presents a promising therapeutic avenue beyond current strategies.
• Further research into HDL functionality could lead to novel treatments for inflammatory cardiovascular diseases.